Here's What I Think Is Going on With Broadcom Stock

Broadcom reported record fiscal Q2 AI semiconductor revenue of $10.8 billion, up 143% year over year, and guided for about $16 billion in AI revenue in fiscal Q3, implying growth of more than 200%. Total revenue rose 48% to $22.2 billion and adjusted EPS increased 54%, but the stock fell about 13% Thursday and another 8% Friday as investors reacted to a rich valuation near 64x earnings and reaffirmed, rather than raised, the company's $100 billion AI revenue target for fiscal 2027.

Analysis

The market is pricing AVGO as if AI demand were a straight-line compounding story with no interruptions, which is exactly why the post-print reaction matters: the issue is not fundamentals, it is positioning. When a mega-cap with a high multiple reports “merely” exceptional results, the first reflex is de-risking by momentum holders, not fundamental sellers; that creates air pockets that can last days to weeks even if the operating trend remains intact.

The bigger second-order implication is competitive, not company-specific. Broadcom’s custom silicon strength reinforces the idea that hyperscalers increasingly want differentiated compute stacks, which is a structural headwind for merchant GPU attach rates and a tailwind for networking and adjacent infrastructure vendors that can ride the same capex cycle. If customer concentration remains high, though, the market will keep assigning a higher probability to program slippage than to upside surprise, so every quarter becomes a binary sentiment event rather than a clean growth comp.

The contrarian read is that holding the long-term AI revenue target unchanged may actually be more bullish than incremental raises: management is signaling confidence in conversion of already-visible demand, not just speculative pipeline. The stock’s drawdown looks like a reset of duration risk, which is useful because it compresses implied expectations without damaging the multi-year thesis. The key question over the next 1-3 months is whether hyperscaler capex data and order commentary confirm that this is still early-cycle spending; if not, valuation can de-rate quickly from a high-60s multiple.

Near term, the setup favors using the decline to express a relative-value view rather than a naked directional bet. If AI infrastructure spending keeps broadening, AVGO should outperform semis with weaker end-market visibility, but if the market shifts from growth to quality, the same concentration risk that helps the story can hurt the stock first.

Key Decisions for Investors

• Buy AVGO only on weakness, staged over 2-4 weeks rather than immediately; risk/reward improves materially if the stock stabilizes after the post-earnings liquidation, but avoid full sizing until implied volatility and momentum reset.
• Pair long AVGO / short a weaker AI infrastructure beneficiary with less earnings visibility over the next 1-2 quarters; the trade expresses continued AI capex without paying for lower-quality execution.
• Use AVGO put spreads 1-3 months out to hedge existing semiconductor exposure; this is a cleaner way to monetize the elevated valuation and customer-concentration risk than outright shorting.
• If you want AI beta, prefer NVDA on pullbacks only after confirmation that hyperscaler spend is broadening; otherwise AVGO remains more idiosyncratic and more exposed to single-program disappointment over the next 1-2 quarters.
• For event-driven traders, fade further downside only if the next hyperscaler capex updates hold firm; absent that confirmation, treat AVGO as a trading range name with downside gaps still possible over the next 30-60 days.